Dowling & Dennis has just added a new client, MDS Nordion, a Canadian company based in Ottawa and maker of the TheraSphere treatment for liver cancer (www.therasphere.com).
TheraSphere is a valuable palliative therapy for patients who have primary liver cancer (originating in the liver) that is inoperable. TheraSphere is a recognized, scientifically documented, minimally invasive therapy performed by interventional radiologists. It’s typically done on an outpatient basis.
For many patients with this serious disease, Therasphere can extend life and improve their quality of life. More than 70 US centers offer the treatment, which is covered by Medicare and many insurance companies.
MDS Nordion products and services are used on a daily basis by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories.